Serum Levels of CD137 Ligand and CD178 are Prognostic Factors for Progression of Myelodysplastic Syndrome

References

• Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R., et al. (1982) "The French-American-British Co-operative Group: proposals for the classification of the myelodysplastic syndromes", British Journal of Haematology, 51, 189–199.
   PubMed Web of Science ®Google Scholar
• Foucar, K., Langdon, R.M., Armitage, J.0., Olson, D.B. and Caro11, T.J. (1985) "Myelodysplastic syndromes. A clinical and pathological analysis of 109 cases", Cancer, 56, 553–561.
   PubMed Web of Science ®Google Scholar
• Mufti, G.J., Stevens, J.R., Oscier, D.G., Hamblin, T.J. and Machin, D. (1985) "Myelodysplastic syndromes: A scoring system with prognostic significance", British Journal of Haematology, 59, 425 — 433.
   Google Scholar
• Weisdorf, D.J., Oken, M.M., Johnson, G.J., and Rydell, R.E. (1983) "Chronic myelodysplastic syndrome: Short survival with or without evolution to acute leukaemia", British Journal of Haematology, 55, 691 —700.
   Google Scholar
• Greenberg, P.L., Cox, C., LeBeau, M.M., Fenawc, P., Morel, P., Sanz, G., Sanz, M., et al. (1997) "International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes", Blood, 89, 2079–2088.
   Google Scholar
• Kato, K., Santana-Sahagun, E., Rassenti, L.Z., Weisman, M.H., Tamura, N., Kobayashi, S., et al. (1999) "The soluble CD40 ligand sCD154 in systemic lupus erythematosus", Journal of Clinical Investigation, 104, 947–955.
   PubMed Web of Science ®Google Scholar
• Jodo, S., Kobayashi, S., Kayagaki, N., Ogura, N., Feng, Y., Amasalci, Y., et al. (1997) "Serum levels of soluble Fas/APO-1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases", Clinical and Experimental Immunology, 107, 89–95.
   PubMed Web of Science ®Google Scholar
• Molica, S., Vitelli, G., Levato, D., Crispino, G., Dell'Olio, M., Dattilo, A., et al. (1998) "CD27 in B-cell chronic lymphocytic leukemia. Cellular expression, serum release and correlation with other soluble molecules belonging to nerve growth factor receptors (NGFr) superfamily", Haematologica, 83, 398–402.
   PubMed Web of Science ®Google Scholar
• Salih, RR., Schmetzer, H.M., Burke, C., Starling, G.C., Dunn, R., Pelka-Fleischer, R., et al. (2001) "Soluble CD137 (4-1BB) ligand is released following leukocyte activation and is found in sera of patients with hematological malignancies", Journal Immunology, 167, 4059–4066.
   PubMed Web of Science ®Google Scholar
• Gersuk, G.M., Beckham, C., Loken, M.R., Kiener, P., Anderson, J.E., Farrand, A., et al. (1998) "A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome", British Journal of Haematology, 103, 176–188.
   Google Scholar
• Mativi, BY., Mundle, S., Ali, A., Bag, K., Venugopal, P., Feldman, G., et al. (1997) "Fas/CD178 system could be one of the mediators of excessive apoptosis in myelodysplastic syndromes", Blood, 90 (Suppl 1), 202.
   Google Scholar
• Gupta, P., Niehans, GA., LeRoy, S.C., Gupta, K., Morrison, V.A., Schultz, C., et al. (1999) "Fos ligand expression in the bone marrow in myelodysplastic syndromes correlates with FAB subtype and anemia, and predicts survival", Leukemia, 13, 44–53.
   Google Scholar
• Trauth, B.C., Klas, C., Peters, AM., Matzku, S., Moller, P., Falk, W., et al. (1989) "Monoclonal antibody-mediated tumor regression by induction of apoptosis", Science, 245, 301 —305.
   Google Scholar
• Igney, F.H., Behrens, C.K. and Krammer, P.H. (2000) "Tumor counterattack-concept and reality", European Journal of Immunol-ogy, 30, 725–731.
   PubMed Web of Science ®Google Scholar
• Salih, H.R., Kosowski, S.G., Haluska, V.F., Starling, G.C., Loo, D.T., Lee, F., et al. (2000) "Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells", Journal of Immunology, 165, 2903–2910.
   PubMed Web of Science ®Google Scholar
• Cannons, J.L., Lau, P., Ghumman, B., DeBenedette, M.A., Yagita, H., Okumura, K., et al. (2001) "4-1BB Ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy", Journal of Immunology, 167, 1313–1324.
   PubMed Web of Science ®Google Scholar
• Claessens, Y.-E., Bouscary, D., Dupont, J.-M., Picard, F., Melle, J., Gisselbrecht, S., et al. (2002) "In vitro proliferation and differentia-tion of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis", Blood, 99, 1594–1601.
   Google Scholar
• Tanaka, M., Itai, T., Adachi, M. and Nagata, S. (1998) "Down-regulation of Fas ligand by shedding", Nature Medicine, 4, 31— 36.
   Google Scholar
• Schneider, P., Holler, N., Bodmer, J.L., Hahne, M., Frei, K., Fontana, A., et al. (1998) "Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of the proapoptotic activity and loss of liver activity", Journal of Experimental Medicine, 187, 1205–1213.
   PubMed Web of Science ®Google Scholar
• Salih, RR., Starling, G.C., Knauff, M., Davis, P.M., Pitts, W.J., Aruffo, A., et al. (2001) "Retinoic Acid and Vitamin E Modulate Expression and Release of CD178 in Carcinoma Cells: Conse-quences for Induction of Apoptosis in CD95 Sensitive Cells", Experimental Cell Research, 270, 248–258.
   PubMed Web of Science ®Google Scholar
• Mazumdar, M. and Glassman, J.R. (2000) "Categorizing a prognostic variable: Review of methods, code for easy implementa-tion and applications to decision-making about cancer treatments", Statistics Medicine, 19, 113–132.
   Google Scholar
• Yoshida, Y. and Mufti, G.J. (1999) "Apoptosis and its significance in MDS: controversies revisited", Leukemia Research, 23, 777–785.
   PubMed Web of Science ®Google Scholar
• Greenberg, P.L. (1998) "Apoptosis and its role in the myelodys-plastic syndromes: implications for disease natural history and treatment", Leukemia Research, 22, 1123–1136.
   Google Scholar
• Michel, J., Pauly, S., Langstein, P., Krammer, P.H. and Schwarz, H. (1999) "CD137-induced apoptosis is independent of CD95", Immunology, 98, 42–46.
   PubMed Web of Science ®Google Scholar
• Langstein, J., Michel, J. and Schwarz, H. (1999) "CD137 induces proliferation and endomitosis in monocytes", Blood, 94, 3161 — 3168.
   Google Scholar
• Deeg, Hi., Beckham, C., Loken, MR., Bryant, E., Lesnikova, M., Shulman, H.M., et al. (2000) "Negative regulators of hemopoiesis and stroma function in patients with myelodysplastic syndrome", Leukemia and Lymphoma, 37, 405–414.
   Google Scholar